Fecal Microbiota Transplantation Improves Cognitive Function of a Mouse Model of Alzheimer's Disease
These findings demonstrate the dose- and time-dependent efficacy of FMT in mitigating AD-like pathology, underscoring the potential of targeting the gut microbiota for AD treatment.
Authors
- Huaiqing Sun (ORCID: https://orcid.org/0009-0008-5579-3163)
- Yu Zheng (ORCID: https://orcid.org/0000-0003-4891-5472)
- Ming Xiao (ORCID: https://orcid.org/0000-0001-5528-9102)
- Yini Dang
- Mengmei Yin (ORCID: https://orcid.org/0009-0001-9731-5329)
- Xueqin Jiang (ORCID: https://orcid.org/0000-0002-0414-4349)
- Ting Wu (ORCID: https://orcid.org/0009-0006-9110-1115)
Institutions
- Nanjing Brain Hospital (CN)
- Jiangsu Province Hospital (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1111/cns.70259
- Citations
- 16
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 12.90
Funders
- National Natural Science Foundation of China
- Nanjing Medical University